\n\n\n\n Studies have also found that BPC-157 protects gastric mucosa from damage induced by alcohol, NSAIDs, and chronic stress in rodent models a finding with significant implications for research into drug-induced gastrointestinal injury, which remains a major clinical problem worldwide
GLP-1 receptor agonists are subject to stringent regulatory requirements that restrain market expansion by increasing development timelines and approval costs
Increased GLP-1 can help with blood sugar regulation and may contribute to weight management
However, further research is required to ascertain the long-term outcomes of GLP-1 RAs in IBD patients, with some studies indicating potential benefits and others highlighting concerns regarding altered gut immunity
10.3389/fmicb.2017.01035 Front
However, these medications have distinct differences in manufacturing, availability, and cost that matter for your treatment decision